D-dimer testing for early detection of venom-induced consumption coagulopathy after snakebite in Australia (ASP-29).


Journal

The Medical journal of Australia
ISSN: 1326-5377
Titre abrégé: Med J Aust
Pays: Australia
ID NLM: 0400714

Informations de publication

Date de publication:
15 08 2022
Historique:
revised: 04 03 2022
received: 29 12 2021
accepted: 16 03 2022
pubmed: 8 6 2022
medline: 17 8 2022
entrez: 7 6 2022
Statut: ppublish

Résumé

To assess the accuracy and marginal value of quantitative D-dimer testing for diagnosing venom-induced consumption coagulopathy (VICC) in people bitten by Australian snakes. Analysis of data for suspected and confirmed cases of snakebite collected prospectively by the Australian Snakebite Project, 2005-2019, from 200 hospitals across Australia. 1363 patients for whom D-dimer was quantitatively assessed within 24 hours of suspected or confirmed snakebite. Diagnostic performance of quantitative D-dimer testing for detecting systemic envenoming with VICC (area under the receiver operating characteristic curve, AUC); optimal D-dimer cut-off value (maximum sum of sensitivity and specificity). D-dimer values exceeded 2.5 mg/L within three hours of the bite for 95% of patients who developed VICC, and were lower than 2.5 mg/L for 95% of non-envenomed patients up to six hours after snakebite. The AUC for diagnosing envenoming with VICC on the basis of quantitative D-dimer testing within six hours of snakebite was 0.97 (95% CI, 0.96-0.98; 944 patients). Diagnostic performance increased during the first three hours after snakebite; for quantitative D-dimer testing at 2-6 hours, the AUC was 0.99 (95% CI, 0.99-1.0); with a cut-off of 2.5 mg/L, sensitivity was 97.1% (95% CI, 95.0-98.3%) and specificity 99.0% (95% CI, 97.6-99.6%) for VICC. For 36 patients with normal international normalised ratio (INR) and activated partial thromboplastin time (aPTT) values 2-6 hours after snakebite, the AUC was 0.97 (95% CI, 0.93-1.0); with a cut-off of 1.4 mg/L, sensitivity was 94% (95% CI, 82-99%) and specificity 96% (95% CI, 94-97%). In all but one of 84 patients who developed VICC-related acute kidney injury, D-dimer values exceeded 4 mg/L within 24 hours of the bite. D-dimer concentrations assessed 2-6 hours after snakebite, with a cut-off value of 2.5 mg/L, could be useful for diagnosing envenoming with VICC.

Identifiants

pubmed: 35670073
doi: 10.5694/mja2.51589
pmc: PMC9541317
doi:

Substances chimiques

Antivenins 0
Elapid Venoms 0
Fibrin Fibrinogen Degradation Products 0
fibrin fragment D 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

203-207

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 The Authors. Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd.

Références

Trans R Soc Trop Med Hyg. 1995 May-Jun;89(3):322-5
pubmed: 7660450
Biochem Soc Trans. 2020 Apr 29;48(2):537-546
pubmed: 32196542
Thromb Res. 2016 Jan;137:219-220
pubmed: 26620264
Thromb Res. 2013 Nov;132(5):610-3
pubmed: 24075725
Toxicon. 2013 Jan;61:94-104
pubmed: 23151381
Pathology. 2021 Jun;53(4):538-540
pubmed: 33172623
Toxicon. 2013 Dec 15;76:103-9
pubmed: 24070638
Clin Toxicol (Phila). 2022 Feb;60(2):205-213
pubmed: 34328386
Med J Aust. 1995 Dec 4-18;163(11-12):616-8
pubmed: 8538559
Clin Toxicol (Phila). 2017 Feb;55(2):115-122
pubmed: 27903075
PLoS Med. 2008 Nov 4;5(11):e218
pubmed: 18986210
Med J Aust. 2010 Sep 6;193(5):285-90
pubmed: 20819048
Clin Toxicol (Phila). 2021 Nov;59(11):956-962
pubmed: 33832399
PLoS Negl Trop Dis. 2015 Aug 21;9(8):e0003968
pubmed: 26296235
Clin Toxicol (Phila). 2013 Jun;51(5):417-24
pubmed: 23586640
Blood Adv. 2020 Sep 22;4(18):4296-4311
pubmed: 32915980
Toxicon. 1994 Sep;32(9):1045-50
pubmed: 7801340
Med J Aust. 2017 Aug 7;207(3):119-125
pubmed: 28764620
Med J Aust. 2010 Dec 6-20;193(11-12):696-700
pubmed: 21143062
Med J Aust. 1992 Dec 7-21;157(11-12):740-6
pubmed: 1453996

Auteurs

Geoffrey K Isbister (GK)

The University of Newcastle, Newcastle, NSW.
Calvary Mater Newcastle, Newcastle, NSW.

Tina Noutsos (T)

Menzies School of Health Research, Darwin, NT.

Shane Jenkins (S)

The University of Newcastle, Newcastle, NSW.

Katherine Z Isoardi (KZ)

Princess Alexandra Hospital, Brisbane, QLD.
Queensland Poisons Information Centre, Queensland Children's Hospital, Brisbane, QLD.

Jessamine Soderstrom (J)

Royal Perth Hospital, Perth, WA.
Western Australia Poisons Information Centre, Sir Charles Gairdner Hospital, Perth, WA.

Nicholas A Buckley (NA)

The University of Sydney, Sydney, NSW.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH